|
What I found that you can expect when taking Lexapro or
Risperdal- risperidone
Your concern
over the damage being done by the drugs is something you should take a look at
and I suspect you already knew they weren't good for you or you wouldn't have
made that comment!
People usually do not
look at the negatives of the medications they take but I am going to show them…
People think their doctor would not give them something to harm them. I’m not
one of those as I've been there and watched it consistently happen for more than
twenty years!
First look at Lexapro;
Liquid and tablets
Contains: Escitalopram oxalate
occurs as a fine, white to slightly-yellow powder and is freely soluble in
methanol and dimethyl sulfoxide (DMSO), soluble in isotonic saline solution,
sparingly soluble in water and ethanol, slightly soluble in ethyl acetate, and
insoluble in heptane.
The tablets also
contain the following inactive
ingredients: talc, croscarmellose sodium, microcrystalline cellulose/colloidal
silicon dioxide, and magnesium stearate. The film coating contains hypromellose,
titanium dioxide, and polyethylene glycol.
Lexapro oral solution
contains escitalopram oxalate
equivalent to 1 mg/mL escitalopram base. It also contains the following inactive
ingredients: sorbitol, purified water, citric acid, sodium citrate, malic acid,
glycerin, propylene glycol, methylparaben, propylparaben, and natural peppermint
flavor.
Lena's remark; I see nothing in there
that will nourish or support the brain but lots that can interrupt the
electrical impulses need to control the organs of the body! These drugs
can impair the oxygen flow through the brain that can and most likely does
create worse Halitosis!
Then Risperdal
Risperdal-
risperidone
RISPERDAL ® is used for
the treatment of schizophrenia in adults and adolescents ages 13-17 years.
RISPERDAL ® is used
alone or in combination with other medicines (valproate or lithium) in adults
for the short-term treatment of bipolar mania; or alone in adults, children and
adolescents ages 10-17 years for the short-term treatment of bipolar mania.
RISPERDAL ® is used for
the treatment of irritability associated with autistic disorder in children and
adolescents ages 5-16 years.
Risperidone is a white
to slightly beige powder. It is practically insoluble in water, freely soluble
in methylene chloride, and soluble in methanol and 0.1 N HCl.
RISPERDAL® tablets
contain the following inactive ingredients: colloidal silicon dioxide,
hypromellose, lactose, magnesium stearate, microcrystalline cellulose, propylene
glycol, sodium lauryl sulfate, and starch (corn). The 0.25 mg, 0.5 mg, 2 mg, 3
mg, and 4 mg tablets also contain talc and titanium dioxide. The 0.25 mg tablets
contain yellow iron oxide; the 0.5 mg tablets contain red iron oxide; the 2 mg
tablets contain FD&C Yellow No. 6 Aluminum Lake; the 3 mg and 4 mg tablets
contain D&C Yellow No. 10; the 4 mg tablets contain FD&C Blue No. 2 Aluminum
Lake.
WARNING: INCREASED
MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
[They actually have this warning on their
website so it must be a huge problem or they wouldn'y put it quite that way!]
Elderly patients with
dementia-related psychosis treated with antipsychotic drugs are at an increased
risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10
weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk
of death in drug-treated patients of between 1.6 to 1.7 times the risk of death
in placebo-treated patients. Over the course of a typical 10-week controlled
trial, the rate of death in drug-treated patients was about 4.5%, compared to a
rate of about 2.6% in the placebo group. Although the causes of death were
varied, most of the deaths appeared to be either cardiovascular (e.g., heart
failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational
studies suggest that, similar to atypical antipsychotic drugs, treatment with
conventional antipsychotic drugs may increase mortality. The extent to which the
findings of increased mortality in observational studies may be attributed to
the antipsychotic drug as opposed to some characteristic(s) of the patients is
not clear. RISPERDAL® (risperidone) is not approved for the treatment of
patients with dementia-related psychosis.
The most common adverse
reactions observed in all clinical trials with RISPERDAL ® occurring at a rate
of at least 10% were somnolence [a state of near-sleep, a strong desire for
sleep, or sleeping for unusually long periods (hypersomnia). It has two distinct
meanings, referring both to the usual state preceding falling asleep, and the
chronic condition referring to being in that state independent of a circadian
rhythm. The disorder characterized by the latter condition is most commonly
associated with the use of prescription medications] Also may experience
increased appetite, fatigue, rhinitis, upper respiratory tract infection,
vomiting, coughing, urinary incontinence, increased saliva, constipation, fever,
tremors, muscle stiffness, abdominal pain, anxiety, nausea, dizziness, dry
mouth, rash, restlessness, and indigestion. Faintness or lightheaded when they
stand up or sit up too quickly.
Neuroleptic
Malignant Syndrome (NMS)
potentially fatal side effect reported with RISPERDAL ® and similar medicines.
Call your doctor immediately if the person being treated develops symptoms such
as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse,
heart rate, or blood pressure; or muscle pain and weakness. Treatment should be
stopped if the person being treated has NMS.
Tardive Dyskinesia (TD)
is a serious, sometimes permanent side effect reported with
RISPERDAL ® and similar medications. TD includes uncontrollable movements of the
face, tongue, and other parts of the body. The risk of developing TD and the
chance that it will become permanent is thought to increase with the length of
therapy and the overall dose taken by the patient. This condition can develop
after a brief period of therapy at low doses, although this is much less common.
There is no known treatment for TD, but it may go away partially or completely
if therapy is stopped.
RISPERDAL ® and similar
medications can raise the blood levels of a hormone known as prolactin, causing
a condition known as hyperprolactinemia. Blood levels of prolactin remain
elevated with continued use.
Some side effects seen
with these medications include the absence of a menstrual period; breasts
producing milk; the development of breasts by males; and the inability to
achieve an erection. The connection between prolactin levels and side effects
is unknown.
High blood sugar and
diabetes have been reported with RISPERDAL ® and similar medications. If the
person being treated has diabetes or risk factors such as being overweight or a
family history of diabetes, blood sugar testing should be performed at the
beginning and throughout treatment. Complications of diabetes can be serious and
even life threatening. If signs of high blood sugar or diabetes develop, such as
being thirsty all the time, going to the bathroom a lot, or feeling weak or
hungry, contact your doctor.
RISPERDAL ® should be
used cautiously in people with a seizure disorder, who have had seizures in the
past, or who have conditions that increase their risk for seizures.
Some people taking
RISPERDAL By standing up or sitting up slowly and following your healthcare
professional's dosing instructions, this side effect may be reduced or it may go
away over time.
Extrapyramidal Symptoms
(EPS) are usually persistent movement disorders or muscle disturbances, such as
restlessness, tremors, and muscle stiffness. If you observe any of these
symptoms, talk to your healthcare professional.
Taken from their own
website:
IMPORTANT SAFETY
INFORMATION FOR RISPERDAL ®
Elderly Patients with
dementia-related psychosis treated with atypical antipsychotic drugs are at an
increased risk of death compared to placebo. RISPERDAL ® (risperidone) is not
approved for the treatment of patients with dementia-related psychosis.
Senior's bodies are made exactly as those younger so this is not limited
to just elderly! I wouldn't put those chemicals in my body if I thought I was dying as it
would definitely speed my death! |